Users online: 1552    [ij] [ij] [ij] 
Email id

Research Journal of Pharmacy and Technology
Year : 2020, Volume : 13, Issue : 7
First page : ( 3184) Last page : ( 3186)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2020.00563.6

Formulation and Evaluation of Oral Dispersion Tablet of Telmisartan

Mahesh PG1,*, Raman S.G.2

1Department of Pharmaceutics, School of Pharmaceutical Sciences, Vels Institute of Science Technology and Advanced Studies, Pallavaram, Chennai-600117

2Department of Chemistry, School of Pharmacy, Sri Balaji Vidyapeeth Deemed to be University, Puducherry, India

*Corresponding Author E-mail: pgmahesh83@gmail.com

Online published on 10 August, 2020.



Telmisartan is used for treatment of a number of infections including infection of joints and bones, gastroenteritis, malignant obits external, respiratory tract infections, cellulites, urinary tract infections, anthrax, skin structural infections, typhoid fever and it also used in treatment of community acquired pneumonia, chronic bacterial prostitis, nosocomial pneumonia etc.


Difficulty in swallowing (dysphasia) is a common problem of all age groups, especially the elderly and pediatrics, because of physiological changes associated with these groups.


In the present work it has been observed from all formulations of Pre compression and post compression studies were given within the limit of values. The in vitro dissolution data, F1 (combination of different super disintegrates) formulation was found that the drug release is best and the cumulative % of drug release was 90.88% respectively, when compared to other formulation.



Gastroenteritis, malignant obits external, dysphasia.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
598,438,516 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.